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Inflammation plays a key role in the development
and progression of diabetic kidney disease; however,
the role of the anti-inflammatory molecule netrin-1 in
diabetic kidney disease is unknown. We examined the
role of netrin-1 in diabetes-induced kidney inflamma-
tion and injury using tubule-specific netrin-1 trans-
genic mice. Diabetes was induced using streptozoto-
cin in wild-type and netrin-1 transgenic animals.
Kidney function, fibrosis, glucose excretion, albumin-
uria, and inflammation were evaluated. The mecha-
nism of netrin-1-induced suppression of inflamma-
tion was studied in vitro using a proximal tubular
epithelial cell line. Diabetes was associated with in-
creased infiltration of neutrophils and macrophages,
chemokine expression, and tubular epithelial cell
apoptosis in kidney. These changes were minimal in
kidney of netrin-1 transgenic mice. In addition, dia-
betes induced a large increase in the excretion of
prostaglandin E2 (PGE2) in urine, which was sup-
pressed in netrin-1 transgenic mice. Netrin-1-induced
suppression of PGE2 production was mediated
through suppression of NFB-mediated cyclooxygen-
ase-2 (COX-2) in renal tubular epithelial cells. Fur-
thermore, netrin-1 also increased albumin uptake by
proximal tubular epithelial cells through the PI3K
and ERK pathways without increasing glucose uptake.
These findings suggest that netrin-1 is a major regu-
lator of inflammation and apoptosis in diabetic ne-
phropathy and may be a useful therapeutic molecule
for treating chronic kidney diseases such as diabeticnephropathy. (Am J Pathol 2012, 181:1991–2002; http://
dx.doi.org/10.1016/j.ajpath.2012.08.014)
Diabetic nephropathy is the largest single cause of end-
stage renal failure worldwide.1 Despite the available
modern therapies of glycemic and blood pressure control
for diabetes, many patients continue to experience pro-
gressive renal damage.2,3 It is extremely important, there-
fore, to identify novel interventions for halting the progres-
sion of diabetic nephropathy. Diabetic nephropathy has
traditionally been considered a nonimmune disease; how-
ever, an increased presence of glomerular and interstitial
immune cell infiltrates and increased expression of inflam-
matory cytokines in diabetic kidney have been reported in
both human biopsies and animal models.4–7 Moreover, re-
cent studies suggest that diabetic nephropathy is also a
tubular disease, and that early changes in tubular epithelial
cells may be a critical factor in development of progressive
kidney diseases.8–12 Inflammation from tubular epithelial
cells can damage other areas of the kidney, including the
vasculature and glomerular mesangial cells, via inflamma-
tory mediators such as prostanoid metabolites, cytokines,
and chemokines. These mediators will induce hyperfiltra-
tion, matrix expansion, apoptosis, and vasodilation, and
further increase the production of their own and other me-
diators of cell injury. Suppression of local inflammation in the
tubular epithelium may therefore provide a more effective
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nephropathy, compared with treatments such as glycemic
and blood pressure control. Recent studies from our labo-
ratory have shown that netrin-1 effectively suppresses in-
flammation in an acute model of kidney disease. However,
the role of netrin-1 in chronic kidney diseases is unknown.
Moreover, the mechanisms as to how netrin-1 suppresses
inflammation are unknown.
Netrin-1 is a laminin-related secreted molecule that
has been identified as a neuronal guidance cue, direct-
ing neurons and their axons to targets during develop-
ment of the nervous system. However, guidance is un-
likely to be the only function of netrin-1, netrins are widely
expressed outside the nervous system, including in vas-
cular endothelial13,14 and kidney tubular epithelial cells.
Vascular endothelial cells form a critical barrier for leuko-
cyte migration into organs by producing repellent factors
to leukocytes, such as netrin-1. Down-regulation of ne-
trin-1 during organ injury is reported to exacerbate in-
flammation.13,14 We have reported that administration or
overexpression of netrin-1 protects the kidney against
ischemia-reperfusion injury.13 However, nothing was
known about the involvement of netrin-1 in diabetic ne-
phropathy, warranting further investigation. The purpose
of the present study was to determine the effect of tubu-
lar-specific overexpression of netrin-1 on diabetes-in-
duced inflammation and nephropathy in mice.
Materials and Methods
Induction of Diabetes
The low-dose streptozotocin (STZ) induction protocol we
followed was as described by the Animal Models of Dia-
betic Complication Consortium (AMDCC), outlined be-
low. The Institutional Animal Care and Use Committee of the
Georgia Health Sciences University approved all protocols
and procedures using animals (approval no. 2011–0348).
Netrin-1 transgenic mice were characterized for transgene
expression and phenotype.15 Eight-week-old netrin-1 trans-
genic mice, which express chicken netrin-1 in proximal
tubular epithelial cells under control of the fatty acid binding
protein promoter, and their wild-type (WT) littermates were
given STZ (50 mg/kg per day in citrate buffer) for 5 days. At
3 weeks after injection, blood glucose was measured. Ani-
mals with a blood glucose level of 350 mg/dL were given
one additional dose of STZ (50 mg/kg). Blood glucose was
measured again 3 weeks after injection and every 4 weeks
thereafter. Renal function and body weight were monitored
every 4 weeks by measuring serum creatinine. At 36 weeks
after induction of diabetes, 24-hour urine was collected and
animals were sacrificed to collect kidney tissue and blood.
Citrate buffer was administered to control animals,
which were subjected to the same treatment as the
diabetic animals.
Laboratory Assessments
Renal function was assessed by measurement of serum
creatinine (DZ072B; Diazyme Laboratories, Poway, CA).Chicken netrin-1 was quantified in plasma and urine
using an enzyme-linked immunosorbent assay (ELISA) kit
(Hölzel Diagnostika, Cologne, Germany). Cytokines and
chemokines in plasma were measured using an ELISA
array kit from SABiosciences (Qiagen, Frederick, MD)
and an ELISA kit from eBioscience (San Diego, CA).
For urine microalbumin quantification by ELISA, 24-
hour urine was collected using a metabolic cage. Urine
volume was measured and the urine was centrifuged at
11,000  g for 10 minutes. The supernatant was ali-
quoted and stored at 80°C until used. Urine albumin
was measured using an ELISA kit (KT-343; Kamiya Bio-
medical, Seattle, WA).
Quantification of mRNA by Real-Time RT-PCR
RNA was isolated using TRIzol reagent (Life Technologies,
Grand Island, NY). Real-time RT-PCR was performed in an
ABI 7700 sequence detection system (Applied Biosystems;
Life Technologies, Foster City, CA). Total RNA (3 g) was
reverse transcribed in a reaction volume of 40 L using an
Omniscript RT kit (Qiagen, Valencia, CA) and random prim-
ers. The product was diluted to a volume of 150 L, and
5-L aliquots were used as templates for amplification us-
ing SYBR Green PCR amplification reagent (Qiagen) and a
mouse inflammatory cytokines and receptors PCR array
(SABiosciences PAMM-011E-4; Qiagen). Data were ana-
lyzed using SABiosciences Web-based analysis tools
(Qiagen).
Cell Culture
Mouse proximal tubular epithelial cells of the TKPT cell
line (a gift from E. Bello-Reuss) were cultured in a low-
glucose (1 g/L) Dulbecco’s modified Eagle’s medium
with 5% serum, which was replaced by serum-free low-
glucose medium 24 hours before the start of the experi-
ment. On the day of experiments, cells were treated with
different concentrations of D-glucose or D-mannitol. Cells
and supernatants were harvested at different times after
glucose addition. The cell pellets were lysed with radio-
immunoprecipitation assay buffer containing protease
and phosphatase inhibitors and used for Western blot
analysis. Some of the cells were used for RNA isolation
and RT-PCR analysis. The supernatants were used for
quantification by ELISA of netrin-1, chemokine, and pros-
taglandin E2 (PGE2).
Prostaglandin and Leukotriene Quantification
PGE2 and leukotrienes B4, D4, and E4 were quantified
in mouse urine and cell culture supernatant using an
enzyme immunoassay kit (Cayman Chemical, Ann Ar-
bor, MI).
Western Blot Analysis
Protein extraction from kidney and TKPTS cells and West-
ern blot analysis were performed as described previ-
ously.13,16 The membrane was probed with goat anti-
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MN), goat anti-mouse netrin-1 antibody (Santa Cruz Bio-
technology, Santa Cruz, CA), fibronectin, -smooth mus-
cle actin (-SMA), rabbit anti-cyclooxygenase-2 (COX-2)
(Abcam, Cambridge, MA), and rabbit anti-IkB antibod-
ies (Cell Signaling Technology, Danvers, MA). Proteins
were detected using enhanced chemiluminescence de-
tection reagents (Amersham Pharmacia; GE Healthcare,
Chalfont St Giles, UK). Protein loading was normalized to
-actin expression using anti-mouse actin antibody
(Sigma-Aldrich, St. Louis, MO).
Histology and Immunostaining
Kidney tissue was fixed in buffered 10% formalin for 12
hours and then embedded in paraffin wax. For assess-
ment of injury, 5-m sections were stained with PAS,
followed by hematoxylin. Acute tubular necrosis and
apoptosis were quantified by determining the percentage
of the tubules that showed epithelial cell necrosis, brush-
border loss, cast formation, and apoptotic bodies in the
cortex. Ten 40 fields were examined and the scores
were averaged. Slides were scored by an individual
(G.R.) masked to the genotype of the animal. To quantify
leukocyte infiltration, sections were stained with rat anti-
mouse neutrophil antibody or anti-mouse macrophage
antibody (1:200 dilution; Abcam), followed by goat anti-
rat biotin conjugate. Color was developed after incuba-
tion with ABC reagent (Vector Laboratories, Burlingame,
CA). Stained sections were photographed, and five 40
fields of neutrophils were examined for quantification of
leukocytes. To determine COX-2 and chicken netrin-1
(transgene) expression, sections were stained with rabbit
anti-COX-2 antibody (1:100 dilution; eBioscience) or goat
anti-chicken netrin-1 antibody (R&D Systems), followed
by goat anti-rabbit biotin or rabbit anti-goat biotin conju-
gate. Color was developed after incubation with ABC
reagent (Vector Laboratories). Stained sections were
photographed using an Olympus inverted microscope
with a color charge-coupled device (CCD) camera
(Olympus USA, Pittsburgh, PA).
To determine the effect of netrin-1 on glucose-induced
NFB activation, TKPTS cells grown on chamber slides
were treated with 600 mg/dL of glucose with and without
100 ng/mL of netrin-1. Cells were washed with PBS at the
end of 3 hours and then were fixed with 10% buffered
formalin for 15 minutes at 4°C, followed by fixation with
methanol for 10 minutes at 20°C. Cells were washed
and blocked with goat serum, followed by incubation with
rabbit anti-p65 antibody for 1 hour. Cells were then
washed and incubated with goat anti-rabbit fluorescein
isothiocyanate conjugate and washed and mounted with
DAPI-containing aqueous mounting medium. Cells were
photographed using an Olympus inverted microscope
with a CCD camera.
TACS TdT Apoptosis Detection in Situ
To identify apoptotic cells, tissue sections were stained
using a TACS TdT-Blue Label in Situ Apoptosis Detection
kit (R&D Systems) according to the manufacturer’s in-structions. Briefly, tissue sections were deparaffinized,
hydrated, and washed with PBS. Sections were digested
with proteinase K for 15 minutes at 24°C. Slides were then
washed, and endogenous peroxidase activity was
quenched with 3% H2O2 in methanol. Slides were
washed and incubated with TdT labeling reaction mix at
37°C for 1 hour and then with streptavidin-horseradish
peroxidase. Color was developed using TACS TdT-Blue
Label substrate solution. Slides were washed, counter-
stained, and mounted with Permount medium. Sections
were photographed, and labeled cells were counted and
quantified.
Morphometry
For each kidney, digital images of 15 randomly chosen
consecutive glomeruli were captured with an Olympus
DP72 color CCD camera mounted on an Olympus light
microscope by moving from cortex to medulla in a ser-
pentine fashion. The glomerular tuft was traced, and the
enclosed area was calculated with Olympus CellSens
Standard software.
Glucose Uptake by Proximal Tubular Epithelial
Cells
TKPTS cells were cultured in 24-well plates to confluency.
On the day of uptake measurements, the culture medium
was removed from the wells by aspiration, and a NaCl-
containing medium (140 mmol/L NaCl, 5.4 mmol/L KCl,
1.8 mmol/L CaCl2, 0.8 mmol/L MgSO4, and 5 mmol/L
D-glucose, buffered with 25 mmol/L HEPES/Tris, pH 7.4)
with or without recombinant netrin-1 (200 ng/mL, final
concentration) was added to the cells. The incubation
time with netrin-1 was varied (10 minutes, 30 minutes, 1
hour, and 3 hours); control cells were treated for corre-
sponding time periods in the absence of netrin-1. At the
end of treatment, the medium was removed by aspiration
and 0.5 mL of uptake buffer containing 0.5 Ci [3H]2-
deoxy-D-glucose as a tracer and 50 mol/L unlabeled
2-deoxy-D-glucose was added to cells, to initiate uptake.
The composition of the uptake buffer was same as that
of the treatment buffer, except that D-glucose was omit-
ted. The incubation time for uptake measurements was
15 minutes. At the end of this incubation period, uptake
was terminated by aspiration of the medium from the
wells, followed by washing of the cells with ice-cold up-
take buffer without any radiolabeled or unlabeled 2-
deoxy-D-glucose three times. Cells were then dissolved in
1% sodium dodecylsulfate/0.2 mol/L NaOH, and the ra-
dioactivity associated with the cell lysates was measured.
Uptake values were normalized to protein. The experi-
ment was performed in triplicate.
Albumin Uptake by Proximal Tubular Epithelial
Cells
Albumin uptake by TKPTS cells was assessed in vitro.
TKPTS cells were grown to 80% confluency and serum-free
medium was added. Bovine serum albumin conjugated
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to the medium at 1 mg/mL concentration. Netrin-1 was
added at different concentrations 30 minutes before albu-
min addition. At 2 hours after addition of albumin, the me-
dium was aspirated and cells were washed thoroughly with
PBS. Cells were then harvested and lysed with PBS-0.1%
Triton X-100. Fluorescence was quantified using a fluores-
cence plate reader (Synergy HT; Biotek Instruments, Win-
ooski, VT). Fluorescence was normalized to mg of total
protein. To determine the role of the ERK and Akt pathways,
specific inhibitors of MEK2 (U0126, 10 mol/L) (Cell Signal-
ing Technology, Inc., Danvers, MA) and PI3K (LY294002,
10 mol/L) were added along with netrin-1.
Statistical Analysis
All assays were performed in duplicate or triplicate. Data
are expressed as means  SEM. Statistical significance
Figure 1. Characterization of transgene chicken netrin-1 expression in nor-
mal and diabetic kidney and plasma. A–D: Localization of chicken netrin-1
(brown) by immunostaining in cortical proximal tubular epithelial cells from
control mouse kidney (A and B) and diabetic mouse kidney (C and D). E and
F: Quantification by ELISA of chicken netrin-1 in plasma (pg/mL or ng/mL)
and urine (pg/mg or ng/mg of urine creatinine) in control (E) and diabetic
(F) netrin-1 transgenic animals; chicken netrin-1 was undetectable in plasma.
G: Expression of transgene chicken netrin-1 in different tissues was deter-
mined by RT-PCR. Transgene expression was seen lung, small intestine,
colon, spleen, and kidney; expression was absent in liver, heart, and brain.
Original magnification: 400 (A and C); 660 (B and D).was assessed by an unpaired, two-tailed Student’s t-test
for single comparisons or by analysis of variance for
multiple comparisons.
Results
Kidney Transgene Expression and Regulation of
Endogenous Netrin-1 during Diabetes
The chicken netrin-1 transgene is highly expressed in
transgenic mouse kidney proximal tubular epithelial cells.
The expression pattern was not altered in the diabetic
state (Figure 1, C and D). High levels of chicken netrin-1
were found in urine from control transgenic mice, and
levels were even higher after induction of diabetes (Fig-
ure 1, E and F). Chicken netrin-1 was undetectable in
Figure 2. STZ-induced type 1 diabetes in WT and netrin-1 transgenic ani-
mals. A: Western blot analysis of the expression of endogenous netrin-1 and
transgene netrin-1 in control and diabetic animal kidney. Endogenous ne-
trin-1 is up-regulated in WT diabetic mouse, but not in netrin-1 transgenic
mouse kidney. Expression of the transgene is not altered with diabetes. B:
Body weight of control and diabetic mice at the start of the experiment and
at week 36. Control animals exhibited a significant increase in body weight,
but diabetic animals did not. ***P  0.001 versus control animals. C: Blood
glucose level was measured at various times after STZ administration. There
was no increase in blood glucose levels in control animals. A significant rise
in blood glucose was seen in STZ-administered animals. There was no
significant difference in blood glucose levels between WT and netrin-1
transgenic diabetic animals. †P  0.0001 versus control animals. D: Albumin
excretion rate in WT and netrin-1 transgenic diabetic and control mice. The
24-hour urine was collected and urine albumin was measured by ELISA.
Diabetes induced a significant rise in the excretion rate of albumin in urine
in WT, which was completely suppressed in netrin-1 transgenic animals.
***P  0.001 versus all other groups. E: Diabetes induced renal dysfunction in
WT and netrin-1 transgenic animals. Kidney function was assessed bymeasuring
serum creatinine at different times after STZ administration. Diabetes induced a
significant rise in serum creatinine in WT diabetic animals, compared with
control animals. ***P  0.001 versus control animals. n  8 to 10. N 1, netrin-1.plasma from control and diabetic transgenic mice, which
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liver (Figure 1G) and blood.17 In addition, netrin-1 recep-
tor UNC5B was localized in the brush border of proximal
tubular epithelial cells in both WT and netrin-1 transgenic
animal kidney, and the localization pattern was not al-
tered in response to diabetes (see Supplemental Figure
S1 at http://ajp.amjpathol.org). Endogenous netrin-1 ex-
pression was minimal in WT control animals and netrin-1
transgenic animal kidney. At 36 weeks after induction of
diabetes, endogenous netrin-1 was up-regulated in WT
Figure 3. Diabetes induces renal fibrosis. A: Fibrosis was determined by
immunostaining for collagen IV and -SMA in kidney tissue sections from
control and diabetic animals. Minimal or negligible staining was seen for both
collagen IV and -SMA in WT control kidney, but staining was significantly
increased in WT diabetic kidney. Both control and diabetic kidney from
netrin-1 transgenic mice showed low or negligible levels of staining for
collagen IV and -SMA. B: Quantification of -SMA expression in kidney by
Western blot analysis. Diabetes significantly increased -SMA expression in
WT mice, compared with control, but not in netrin-1 transgenic diabetic
mouse kidney. *P  0.05 versus all other groups.mice, but not in transgenic mice (Figure 2A). Our recentin vitro studies demonstrated that hyperglycemia down-
regulated netrin-1 production in TKPTS cells; however,
high levels of protein (20 mg/mL of endotoxin-free bovine
serum albumin) in the medium induced netrin-1 produc-
tion, suggesting that tubular injury and proteinuria are a
signal for induction of netrin-1.18 It is possible, therefore,
that hyperglycemia-induced down-regulation of endoge-
Figure 4. Netrin-1 overexpression reduces diabetes-induced necrosis and
apoptosis of tubular epithelial cells in kidney. Top: Necrosis and apoptosis
were assessed in kidney cortex using PAS-stained tissue sections. Control
nondiabetic kidney from WT and netrin-1 transgenic mice shows normal
tubular structure, but WT diabetic kidney shows high levels of tubular
atrophy, apoptosis, and necrosis, which is significantly attenuated in diabetic
netrin-1 transgenic mouse kidney. Bottom left panel: Quantification of
apoptosis, necrosis, and tubular atrophy expressed as tubular injury score in
five 40 fields from kidney cortex. Bottom right panel: Netrin-1 overex-
pression suppresses caspase-3 expression and activation in diabetic kidney.
Control nondiabetic kidney from WT and netrin-1 transgenic mice shows no
staining for active caspase-3, but staining was increased in WT diabetic
kidney; this increase was significantly attenuated in diabetic netrin-1 trans-
genic mouse kidney. Caspase-3 mRNA expression in nondiabetic and dia-
betic WT and transgenic mouse kidney was analyzed by real-time RT-PCR.
Red arrows indicate the fragmented apoptotic nuclei. Yellow outline
indicates active caspase-3 staining in the proximal tubular epithelial cells.
***P  0.001 versus all other groups. n  6 to 8.
n the int
nimals, *
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cells to increased inflammation and cell death.
Effects of Netrin-1 Overexpression
Blood Glucose and Body Weight
There was no significant increase in body weight in
diabetic mice, whether WT or netrin-1 transgenic (Figure
2B). Control mice gained weight, as expected. Blood
glucose levels were increased significantly in diabetic
mice after STZ injection and continued to be elevated
throughout the study period, but were not elevated in
citrate buffer-treated control groups (Figure 2C).
Urinary Albumin Excretion
The urinary albumin excretion rate was 28  3 g/24
hours (17  3 g/mg of creatinine) in the WT control
group and increased to 48  5 g/24 hours (91  12
g/mg of creatinine) (P  0.05) at week 36 in the WT
diabetic group (Figure 2D). This effect was significantly
reduced in netrin-1 transgenic mice, to 26  8 g/24
hours (42  18 g/mg of creatinine) (P 0.05 versus WT
diabetic mice), with no significant difference seen be-
Figure 5. Netrin-1 suppresses diabetes-induced inflammation in kidney. A
RT-PCR. Diabetic WT mouse kidney showed a significant increase in expr
transgenic diabetic mice. B: Cytokine and chemokine excretion in 24-hour uri
is increased in WT diabetic mice, compared with netrin-1 transgenic mice.
anti-neutrophil antibody. C: WT control kidney shows no neutrophils. D:
transgenic control kidney shows no neutrophil staining. F: Netrin-1 transgenic
by counting cells in five 40 fields.H–K:Macrophage infiltration (indicated by a
H: WT control kidney shows macrophage staining in the interstitium but no
glomerulus. J: Netrin-1 transgenic control kidney shows macrophage staining i
shows little macrophage staining in the glomerulus. *P  0.05 versus control atween netrin-1 transgenic control and diabetic mice.Renal Function
Renal function deteriorated modestly but significantly,
as shown by the increasing levels of serum creatinine in
diabetic WT mice at 36 weeks (Figure 2E), compared with
control mice. Although netrin-1 transgenic mice showed
a rise in serum creatinine, compared with control mice,
but the difference did not reach statistical significance.
Control mice, both WT and transgenic, did not show any
renal dysfunction at 36 weeks.
Renal Fibrosis
Very low or negligible levels of staining were seen in
nondiabetic control WT and netrin-1 transgenic animal
kidney, whereas a large increase in immunostaining for
both collagen IV and -SMA was seen in WT diabetic
kidney. Diabetes-induced increased expression of colla-
gen and SMA was abolished in netrin-1 transgenic mice,
as shown by low levels of staining (Figure 3). Quantitative
data for -SMA expression in kidney by Western blot
analysis are presented in Figure 3B. Diabetes signifi-
cantly increased (P  0.05) -SMA expression in WT
mice, compared with control, but -SMA expression was
suppressed in the netrin-1 transgenic diabetic mouse
y cytokine and chemokine gene expression was determined by real-time
f many cytokine and chemokine genes, which was suppressed in netrin-1
etermined by ELISA. Excretion of several cytokines and chemokines in urine
eutrophil infiltration into kidney was determined by immunostaining with
betic kidney shows increased neutrophil infiltration (arrows). E: Netrin-1
mouse kidney shows few neutrophils. G: Neutrophil infiltration was quantified
nto kidney was determined by immunostaining with anti-macrophage antibody.
omerulus. I: WT diabetic kidney shows increased macrophage infiltration in
erstitium but not the glomerulus. K: Netrin-1 transgenic diabetic mouse kidney
**P  0.001 versus all other groups. n  4.: Kidne
ession o
ne was d
C–F: N
WT dia
diabetic
rrows) i
t the glkidney.
(G) or v
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Epithelial Cell Apoptosis and Necrosis in Kidney
There was no increase in apoptosis and necrosis of the
tubules in control animal kidney, both WT and netrin-1
transgenic (Figure 4); however, diabetes induced a large
increase in necrosis, atrophy, and apoptosis in tubular
Figure 6. Regulation of COX-2 and PGE2 production by netrin-1 in viv
control (A and B) shows no staining; nondiabetic WT kidney (C) shows
netrin-1 transgenic mouse kidney (D) shows diffuse low level of stainin
intense staining in the proximal tubular epithelial cells; and diabetic netrin
tubular epithelial cells. G: Hyperglycemia significantly up-regulated COX
kidney, as determined by real-time RT-PCR. Netrin-1 overexpression com
synthase (Ptgis) expression also increased moderately but significantly in
mouse kidney. Expression of COX-1, prostaglandin E synthase 2 (Ptges2
quantified by enzyme immunoassay. PGE2 excretion was increased in WT
blot analysis and quantification of COX-2 protein expression in control an
but not in the other groups. *P  0.05 versus nondiabetic control kidney
(G) or versus all other groups (H). n  6.epithelial cells. Overexpression of netrin-1 in tubular ep-ithelial cells attenuated this diabetes-induced necrosis
and apoptosis (Figure 4). Consistent with observations in
PAS-stained tissue section, TUNEL staining showed a
similar result. Apoptotic nuclei were seen in both tubular
epithelium and glomerulus of WT diabetic kidney, but
apoptosis was significantly suppressed in netrin-1 trans-
genic mouse kidney (see Supplemental Figure S2 at
COX-2 localization in control and diabetic kidney. Secondary antibody
low level of staining in the proximal tubular epithelial cells; nondiabetic
proximal tubular epithelial cells; diabetic WT mouse kidney (E) shows
enic mouse kidney (F) shows diffuse low level of staining in the proximal
ession in WT diabetic mouse kidney, compared with WT control mouse
suppressed hyperglycemia-induced COX-2 expression. Prostaglandin I2
abetic kidney, but expression was down-regulated in netrin-1 transgenic
rostaglandin-D2 synthase (Ptgds) was unchanged. H: PGE2 in urine was
c mouse, compared with control and diabetic transgenic mice. I: Western
tic mouse kidney revealed significant upregulation in WT diabetic kidney,
ersus all other groups (I); ***P  0.001 versus diabetic WT mouse kidneyo. A–F:
diffuse
g in the
-1 transg
-2 expr
pletely
WT di
), and p
diabeti
d diabehttp://ajp.amjpathol.org). To determine whether netrin-1
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apoptosis, activated caspase-3 staining was per-
formed. No increase in active caspase-3 staining was
seen in tubules of control animal kidney, both WT and
netrin-1 transgenic (Figure 4); however, diabetes in-
duced a large increase in the activation of caspase-3
in tubular epithelial cells. Overexpression of netrin-1 in
tubular epithelial cells suppressed diabetes-induced acti-
vation of caspase-3. Furthermore, expression of caspase-3
expression was also increased significantly in diabetic WT
kidney, compared with either control or diabetic netrin-1
transgenic mouse kidney.
Netrin-1 Overexpression Regulates
Inflammatory Cytokine Expression and Excretion
Chronic diabetes increased the expression of several
cytokines and chemokines and their receptors in the kid-
ney (Figure 5A). Netrin-1 overexpression in tubular epi-
thelial cells significantly suppressed the expression of
these cytokines and chemokines and their receptors.
Consistent with reduced expression of cytokines and
chemokines in kidney, the excretion of cytokines and
chemokines was reduced in urine of netrin-1 transgenic
animals, compared with WT diabetic animals (Figure 5B).
Most of the cytokines and chemokines analyzed were
undetectable or present in very low levels in the urine of
control mice. Chronic diabetes in WT mice showed in-
creased excretion of a cytokine (IL-1) and chemokines(MCP-1, SDF-1, and IP-10). However, the excretion of
these cytokines is significantly suppressed in diabetic
netrin-1 transgenic mice.
Netrin-1 Overexpression Suppresses Diabetes-
Induced Leukocyte Infiltration into Kidney
Consistent with the improvement in renal function and
reduced cytokine and chemokine expression in netrin-1
transgenic diabetic mouse kidney, neutrophil (Figure 5,
C–G) and macrophage (Figure 5, H–K) infiltration was
reduced significantly, compared with WT diabetic mouse
kidney.
Netrin-1 Overexpression Suppresses Diabetes-
Induced Prostaglandin Production in Kidney
The mechanism responsible for netrin-1-mediated sup-
pression of inflammation is unknown. We hypothesized
that netrin-1 regulates inflammation through suppres-
sion of COX-2-mediated PGE2 production. Hypergly-
cemia caused a large increase in COX-2 enzyme
expression in WT mouse kidney, compared with non-
diabetic control (Figure 6G). Netrin-1 overexpression
completely suppressed this diabetes-induced COX-2
expression. COX-1 expression was not altered signifi-
cantly. Consistent with the increase in mRNA expres-
sion, expression of COX-2 protein increased signifi-
Figure 7. Hyperglycemia-induced COX-2 expres-
sion and NFB activation are suppressed by ne-
trin-1 in proximal tubular epithelial cells. A:
TKPTS cells treated with increasing concentration
of glucose with or without netrin-1 (100 ng/mL).
Supernatant was harvested at 24 hours after addi-
tion of glucose and PGE2 was quantified by en-
zyme immunoassay. Glucose induced PGE2 pro-
duction, but this effect was significantly attenuated
by netrin-1. B: Western blot analysis of IkB deg-
radation in TKPTS cells in response to high levels
of glucose. High levels of glucose induced a rapid
degradation of IkB, which was suppressed in the
presence of netrin-1. Glucose is normal at hour 0.
C: TKPTS cells were incubated with different con-
centrations of D-glucose or D-mannitol in the pres-
ence of netrin-1. Cells were harvested at 0 to 24
hours (glucose) or at 1 or 3 hours (mannitol), and
Western blot analysis was performed for COX-2
expression. Glucose increased COX-2 expression
in a dose- and time-dependent manner; the effect
was suppressed by addition of netrin-1. The os-
motic agent D-mannitol alone did not increase
COX-2 expression. D–G: Immunocytochemical
analysis of glucose-induced NFB activation in
TKPTS cells. Secondary antibody control (D)
shows no staining for NFB (green; blue staining
is DAPI); untreated control (E) shows cytoplasmic
localization of p65 subunit of NFB. At 3 hours
after addition of 600 mg/dL glucose (F), nuclear
localization of p65 subunit of NFB is observed.
Addition of netrin-1 (G) suppressed activation of
NFB, as indicated by cytoplasmic localization of
p65 subunit. *P  0.05 versus glucose  netrin-1.
n  6.cantly (Figure 6I), but expression was completely
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sistent with the increase in COX-2 expression, the lev-
els of PGE2 in urine were increased in WT diabetic
mice, compared with control mice. The diabetes-in-
duced increase in PGE2 excretion was robustly sup-
pressed in netrin-1 transgenic animals with diabetes
(Figure 6H).
To determine the cell type that overexpresses COX-2,
immunolocalization was performed. COX-2 staining was
minimal in nondiabetic control mouse kidney, both WT
and netrin-1 transgenic (Figure 6, C and D). Diabetes
induced a large increase in immunostaining for COX-2 in
the cortical tubules (proximal tubular epithelial cells) (Fig-
ure 6E), but netrin-1 transgenic diabetic animal kidney
did not show any increase in COX-2 staining (Figure 6F).
These results suggest that netrin-1 may suppress inflam-
mation by inhibiting the production of COX-2-generated
metabolites.
Hyperglycemia-Induced Increase in PGE2 Is
Suppressed by Netrin-1 in TKPTS Cells
To determine directly the effect of netrin-1 on hypergly-
cemia-induced production of PGE2, TKPTS cells were
treated with increasing doses of D-glucose with and with-
Figure 8. Glucose and PGE2 induced cytokine and chemokine production
in mouse proximal tubular epithelial cells. A: Cells were incubated with
increasing concentration of D-glucose with and without netrin-1. MCP-1
production was quantified in the cell supernatant by ELISA. High levels of
glucose (800 mg/dL) induced MCP-1 production in TKPTS cells; this effect
was significantly attenuated in the presence of netrin-1. D-mannitol alone did
not increase MCP-1 production, suggesting that the glucose effect is not due
to osmotic effect. The 100 mg/dL glucose level served as control. B: PGE2-
induced IL-1 expression in TKPTS cells. PGE2-induced IL-1 expression
was analyzed by real-time RT-PCR. C: PGE2 induced IP-10 production in a
dose-dependent manner. TKPTS cells were treated with increasing concen-
tration of PGE2 and supernatant was harvested after 24 hours. IP-10 was
quantified by ELISA. D: PGE2 (250 ng/mL) induced IP-10 expression signif-
icantly, compared with control, in TKPTS cells. *P 0.05 versus high glucose
(A) or versus control (D); ***P  0.001 versus control (A–C). n  4.out netrin-1. Glucose induced PGE2 synthesis in a dose-dependent manner, but synthesis was suppressed in the
presence of netrin-1 (Figure 7). An increasing dose of
D-mannitol (an osmotic agent) did not increase PGE2
synthesis, suggesting that increased PGE2 production in
diabetes is specific to glucose (Figure 7A). To determine
whether hyperglycemia induces COX-2 enzyme expres-
sion, thereby increasing PGE2 production, COX-2 ex-
pression in TKPTS cells was quantified by Western blot.
Glucose increased COX-2 enzyme expression in a dose-
and time-dependent manner, but expression was sup-
pressed by netrin-1 (Figure 7B). These results suggest
that netrin-1 reduces inflammation by suppressing
COX-2 expression and PGE2 production in tubular ep-
ithelial cells.
Netrin-1 Mediates Suppression of
Glucose-Induced NFB Activation
The signaling pathway through which netrin-1 sup-
presses COX-2 expression is unknown. The COX-2 pro-
moter, however, has an NFB-binding site and is up-
regulated in response to NFB activation. Hyperglycemia
is known to activate NFB. We therefore investigated
whether glucose-induced activation of NFB is sup-
pressed by netrin-1 in TKPTS cells. D-Glucose induced
COX-2 expression in a dose- and time-dependent man-
ner, but addition of netrin-1 significantly suppressed
COX-2 expression (Figure 7C). The induction of COX-2
was associated with an increase in NFB activation, as
seen by nuclear translocation of the p65 subunit, which
was suppressed in netrin-1-treated cells (Figure 7, D–G).
Moreover, glucose induced degradation of IkB, which is
suppressed by netrin-1, suggesting that netrin-1-medi-
ated suppression of COX-2 may occur through IkB-
mediated inhibition of NFB.
Glucose and PGE2 Induce Inflammatory
Cytokine and Chemokine Production in Renal
Tubular Epithelial Cells
Hyperglycemia induced PGE2 production by increas-
ing the expression of COX-2 (Figure 7). To determine
whether high glucose levels or PGE2 increases inflam-
matory responses in the tubular epithelial cells, we mea-
sured cytokine and chemokine expression in response to
glucose and PGE2. Incubation of TKPTS cells in high
levels of glucose, but not mannitol, induced a signifi-
cant increase in MCP-1 production, which was attenu-
ated by netrin-1 (Figure 8A). Moreover, addition of
PGE2 induced a dose-dependent increase in IP-10
production (Figure 8, C and D) and induced IL-1
expression as well (Figure 8B).
Netrin-1 Overexpression Suppresses
Hyperglycemia-Induced Glomerular Mesangial
Expansion
COX-2 has been shown to exacerbate mesangial expan-
sion, a hallmark of diabetic nephropathy.19 Because ne-
trin-1 suppressed hyperglycemia-induced COX-2 ex-
ith vehi
rsus all
2000 Mohamed et al
AJP December 2012, Vol. 181, No. 6pression and PGE2 production, we quantified the
glomerular area using cell scanning software (Olympus
cellSens). No significant difference in mesangial area
was seen in WT control and netrin-1 transgenic control
mice (Figure 9, A and B). Diabetes induced a significant
increase in mesangial expansion as seen by an in-
crease in glomerular area (Figure 9C), which was com-
pletely suppressed in netrin-1 transgenic mice (Figure
9D). Quantitative data for glomerular area are shown in
Figure 9E.
Netrin-1 Regulates Albumin Uptake in Renal
Proximal Tubular Epithelial Cells
Netrin-1 increased the uptake of albumin by proximal
tubular epithelial cells (TKPTS) in a dose-dependent
manner (Figure 9F). Based on our earlier study,20 the role
of PI3 kinase and ERK pathways on netrin-1-mediated
albumin uptake was determined using pathway-specific
inhibitors. Both pathway inhibitors suppressed netrin-1-
Figure 9. Diabetes-induced increase in glomerular area is suppressed b
measured in nondiabetic WT mouse kidney (A), nondiabetic netrin-1 tra
transgenic mouse kidney (D). E: Quantification of glomerular area reveale
albumin uptake through ERK and PI3 kinase pathways. Albumin uptak
suppressed in the presence of PI3 kinase and ERK MAP kinase inhibitors
compared with control mice; this effect was not altered in netrin-1 trans
significant increase in 2-deoxy-D-glucose uptake by netrin-1, compared w
control and †P  0.05 versus netrin-1-treated group (F); ***P  0.001 veinduced albumin uptake (Figure 9F), suggesting that ne-trin-1 increases albumin uptake through the ERK and Akt
pathways. To determine whether the netrin-1 effect on
increased albumin uptake is due to effective reabsorption
of glucose by tubular epithelial cells, urine glucose and
glucose uptake by TKPTS cells were measured. Diabe-
tes caused a large increase in glucose excretion,
which was not reduced in netrin-1 transgenic diabetic
mice (Figure 9G). Moreover, glucose uptake by TKPTS
cells was also not significantly altered in the presence
of netrin-1 (Figure 9H).
Discussion
Inflammation is a major contributing factor in deterioration of
kidney function due to chronic diabetes.21,22 Increasing
evidence suggests that individuals who progress to diabe-
tes mellitus display features of inflammation years before
disease onset.6,23 The axon-guidance molecule netrin-1 is
known to regulate inflammation and apoptosis in tubular
epithelial cells in an acute kidney injury model in mice.15,24
-1 overexpression in tubular epithelial cells. A–D: Glomerular area was
mouse kidney (B), diabetic WT mouse kidney (C), and diabetic netrin-1
ficant increase in area in WT diabetic mouse kidney. F: Netrin-1 increases
measured. Netrin-1 significantly increased albumin uptake, which was
cose excretion in urine was increased significantly in WT diabetic mice,
iabetic mice. H: Glucose uptake by TKPTS cells in vitro. There was no
cle-treated control, irrespective of the treatment period. *P  0.05 versus
other groups (E); ‡P  0.0001 versus control (G). n  5.y netrin
nsgenic
d signi
e was
. G: Glu
genic dHowever, whether netrin-1 has a similar role in chronic
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known. In the present study, at 36 weeks after induction
of diabetes in WT mice (C57BL/6), a marked increase in
albuminuria, reduction of renal function, and histological
changes characteristic of diabetic nephropathy were es-
tablished. Furthermore, these changes were associated
with evidence of inflammation, which was suppressed by
netrin-1 overexpression in proximal tubular epithelial
cells. We show here, for the first time, that netrin-1 sup-
presses inflammation through suppression of diabetes-
induced COX-2 expression and PGE2 production. The
suppressive effect on COX-2 was mediated through in-
hibition of NFB activation. In addition, we show that part
of the netrin-1-mediated reduction in albuminuria occurs
through increased uptake of albumin by proximal tubular
epithelial cells via activation of PI3k and ERK pathways.
The overall mechanism of netrin-1-mediated renal protec-
tion is summarized in Figure 10.
Netrin-1 is overexpressed in proximal tubular epithelial
cells, is secreted into tubule lumen, and is excreted in
urine.15 The large size of the netrin-1 molecule and the
directional flow of urine make it harder for netrin-1 to act
on the glomerulus. Thus, the observed reduction in albu-
minuria is unlikely due to netrin-1 effects on the glomer-
ulus. This view was further supported by immunostaining
data for chicken netrin-1 and the total absence of chicken
netrin-1 in plasma. Recent studies suggest that albumin
is filtered through the glomerulus, and that renal tubular
epithelial cells actively reabsorb albumin from the lumen.
Any defect in tubular epithelial cells will increase excre-
tion of albumin.9,25,26 Our in vitro studies suggest that part
of the netrin-1-mediated protective effect may occur
through increased albumin uptake by proximal tubular
Figure 10. Model summarizing the role of netrin-1 in the regulation of
inflammation and albumin uptake in proximal tubular epithelial cells of the
diabetic kidney. Hyperglycemia and oxidative stress activate NFB by induc-
ing degradation of IB. Netrin-1 binding to UNC5B receptor will activate
downstream signaling pathways like PI3K, ERK, and other unknown path-
ways. Activation of PI3K and ERK increases albumin uptake by tubular
epithelial cells, thereby reducing albuminuria. Through an unknown path-
way, netrin-1 also suppresses IB degradation and probably may increase
the expression of IB as well, thereby suppressing NFB release and
translocation into nucleus and consequently suppressing COX-2 gene tran-
scription. Suppression of COX-2 expression reduces the production of PGE2
and PGE2-mediated inflammation, and suppression of inflammation protects
the kidney from damage and from development of nephropathy.epithelial cells.An increase in the number of kidney neutrophils was
seen in diabetic nephropathy, but the role of neutrophils
in the progression of diabetic nephropathy is not clear.27
In the kidney, MCP-1 is produced by mesangial and
tubular epithelial cells28,29 and mediates renal interstitial
inflammation, tubular atrophy, and interstitial fibrosis.30 In
the present study, we found significant elevation of uri-
nary MCP-1 excretion and kidney expression with the
progression of diabetes, which was associated with in-
creased macrophage infiltration, suggesting that MCP-1
may play a role in increased urinary albumin excretion. In
diabetes, urinary excretion of MCP-1 is due to MCP-1
production by the kidney.31 These data suggest the pos-
sibility that renal MCP-1 may contribute to the glomerular
and tubulointerstitial lesions in diabetic nephropathy. Ne-
trin-1-mediated suppression of urinary albumin may be
mediated through suppression of MCP-1 production from
renal epithelial cells. Macrophage infiltration into intersti-
tium and into glomerulus was suppressed by tubule ep-
ithelial netrin-1. Although direct action of netrin-1 on glo-
merular macrophages is not possible, plausible indirect
mechanisms include suppression of MCP-1 chemokines,
reduction in glomerular hyperfiltration, and damage
through suppression of PGE2 production and suppres-
sion of overall inflammation in the kidney.
The mechanism through which netrin-1 suppresses
inflammation has been unknown. Here, we report for the
first time that netrin-1 regulates prostanoid metabolism
through COX-2 expression. Our in vitro results confirm the
in vivo findings that netrin-1 suppresses hyperglycemia-
induced PGE2 production and COX-2 expression. In ad-
dition, netrin-1 inhibited hyperglycemia-induced NFB
activation. Moreover, the addition of PGE2 induced
chemokine and cytokine production from renal tubular
epithelial cells. COX-2 and PGE2 have been linked to
diabetic nephropathy in animal models.19,32–34 In addi-
tion to suppression of PGE2, netrin-1 also suppresses the
production of leukotrienes (LTE4) in vivo (data not shown).
Leukotrienes are known mediators of inflammation and
have been implicated in diabetic nephropathy.35,36 The
expression of prostaglandin E synthase 2 was not in-
creased. Our results therefore suggest that netrin-1 sup-
presses inflammation through suppression of COX-2-me-
diated PGE2 production. The contribution of leukotriene
suppression in netrin-1-mediated down-regulation of in-
flammation is not clear and needs further study.
In development of microalbuminuria, impaired tubular
reabsorption of albumin plays a major role, in addition to
glomerular hyperfiltration of albumin.25 The importance of
tubular epithelial cells in development of proteinuria was
reinforced by the recent observation that a human cubilin
mutation caused proteinuria37 and that proximal tubular
epithelial cell-specific cubilin knockout mice also devel-
oped albuminuria.38 Here, we show for the first time that
proximal tubular epithelial cell-specific overexpression
suppresses albuminuria, which reconfirms the impor-
tance of proximal tubular epithelial cells in controlling
proteinuria. These results suggest that the reduction in
albuminuria seen in vivo in transgenic animals may be
mediated in part through increased uptake of albumin by
proximal tubular epithelial cells. Netrin-1 is induced in
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lar injury.39 Our recent in vitro studies suggest that in-
creased albumin can induce the expression of netrin-1,
whereas a high glucose level suppresses netrin-1 ex-
pression.18 Nonetheless, the involvement of netrin-1 up-
regulation in diabetes is not clear.
In summary, the present study demonstrates that
chronic diabetes induces renal dysfunction, necrosis, tu-
bular atrophy, apoptosis, increased expression of cyto-
kines and chemokines, and increased excretion of albu-
min in urine, characteristics of diabetic nephropathy that
are seen in WT mice. Netrin-1 overexpression in tubular
epithelial cells suppressed both structural and functional
abnormalities, which may be mediated through suppres-
sion of inflammation and apoptosis. We conclude that
netrin-1 administration represents a novel therapeutic op-
tion for the treatment of diabetic kidney disease and
potentially for other diabetic complications.
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